InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Salas Eduardo Rene. Director active across 2 companies, notably Intra-Cellular Therapies, Inc.. In total, 4 disclosures have been logged. Activity tracked since 19 February 2025. The latest transaction was disclosed on 9 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Salas Eduardo Rene is a declarant connected with Adma Biologics, INC. and Intra-Cellular Therapies, Inc., where he is a Director. He has 4 filings in total, and among the recent sampled filings the activity runs from 2024-06-25 to 2026-02-11, with EUR 0 in buys and EUR 189614 in sells; the modal transaction nature is Attribution.